tiprankstipranks
Newamsterdam Pharma Company N.V. (NAMS)
NASDAQ:NAMS
US Market
NAMS
NewAmsterdam Pharma Company
RESEARCH TOOLSreports
Want to see NAMS full AI Analyst Report?

NewAmsterdam Pharma Company (NAMS) Cash flow

251 Followers

NewAmsterdam Pharma Company Cash Flow

NAMS's free cash flow for Q1 2026 was $-30.64M. For the 2026 fiscal year, NAMS's free cash flow was decreased by $11.21M and operating cash flow was $-30.60M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Mar 23Dec 21
Operating Cash Flow
$ -147.78M$ -158.56M$ -141.22M$ 10.66M$ -29.51M
Investing Cash Flow
$ -174.92M$ -62.85M$ -24.00K$ -221.00K$ -24.00K
Financing Cash Flow
$ 29.52M$ 659.51M$ 8.91M$ 391.90M$ 84.70M
End Cash Position
$ 491.32M$ 771.74M$ 340.45M$ 467.73M$ 60.13M
Free Cash Flow
$ -148.03M$ -159.24M$ -141.24M$ 10.44M$ -29.54M
Currency in USD

NewAmsterdam Pharma Company Cash Flow